Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1317 clinical trials
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors

An ascending dose study in patients with solid tumors to evaluate the safety, tolerability, pharmacodynamics and efficacy of APG-1387 in combination with toripalimab. A phase II study of 3 cohorts will be included.

brain metastasis
cancer
EGFR
hair thinning
immunohistochemistry
  • 0 views
  • 19 Feb, 2024
Effect of Single Dose Antenatal Betamethasone on Neonatal Respiratory Morbidity After Elective Cesarean

Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will receive placebo.

betamethasone
respiratory morbidity
  • 0 views
  • 19 Feb, 2024
A Study of TTYP01 in Healthy Adult Subjects

In Part B, 16 healthy adults will be randomized into 2 groups, and the comparison of the PK of edaravone (TTYP01 and intravenous (IV) edaravone) will be evaluated using a randomized, open-label, four-period crossover design under fasted conditions.

  • 0 views
  • 19 Feb, 2024
Supplementary Implants Supporting Conventional Removable Dental Prosthesis (RDPs) in Kennedy Class I

In this study the additional effect of supplementary implants in patients with Kennedy Class I in terms of patient-reported outcome measures (PROMs) and cost-benefit-analyses comparing costs of maintenance care will be investigated

  • 0 views
  • 19 Feb, 2024
Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer

Tolerance of the endocrine therapy will be assessed by patient reported outcome (PRO) measures during neoadjuvant and adjuvant endocrine therapy treatment periods. Breast cancer participants and their surgical oncologists will be asked their preference regarding radiation therapy before starting endocrine therapy and again post-operatively.

aromatase inhibitor
cancer
HER2
estrogen receptor positive breast cancer
invasive breast cancer
  • 0 views
  • 19 Feb, 2024
Genetic Characteristics of Metastatic Breast Cancer Patients

Genomic analysis for metastatic breast cancer(MBC) patients Participant (Inclusion criteria) Patients who diagnosed metastatic/stage IV breast cancer Patients who were not received treatment for metastatic breast cancer on palliative setting Process (1) Tissue/ Blood sample At diagnosis, MBC tissue / blood sample (20cc) will be obtained. At disease progression after …

breast cancer
stage iv breast cancer
cancer
  • 0 views
  • 19 Feb, 2024
Insertion of PICC With Intracavitary ECG Navigation

The study subjects who are indicated for peripherally inserted central (PICC) catheter placement will undergo this procedure under the control of ECG, the correct position of the PICC catheter tip will be subsequently verified X-ray imaging.

  • 0 views
  • 19 Feb, 2024
A Clinical Trail of Traditional Chinese Medicine Rehabilitation for Stroke Lead to Dysphagia / Cognitive Disorder

The traditional Chinese medicine rehabilitation for the deglutition and cognitive impairment after stroke will be intervened, which can promote the recovery of dysphagia and cognitive function of stroke patients, reduce the disability rate and improve the quality of life.

dysphagia
infarct
cerebral infarction
ischemic stroke
acupuncture
  • 0 views
  • 19 Feb, 2024
S0820, Adenoma and Second Primary Prevention Trial (PACES)

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing the event rate of adenomas and second primary colorectal cancers at three years in patients previously treated for stage 0 to III colon or rectal cancer.

  • 0 views
  • 02 Dec, 2024
  • 1 location
2 march edit9  

Based on the Stage 1 analysis performed in November 2014, Arm 1 was chosen for expansion in Stage 2. Stage 2 dose will be 1-5x10xE8 transduced CART-19 cells. The dose of 1-5 x 10xE8 T-cells in Stage 2 will be administered via split dosing: 10% on Day 1 (1-5x10xE7), 30% …

  • 0 views
  • 26 Sep, 2024
  • 1 location